Loading…
Any Concern About Delays in the Diagnosis of Childhood Cancers During the COVID-19 Pandemic?
The lockdown precautions during the COVID-19 pandemic led to concerns about the delayed diagnosis of malignancies. This study aimed to compare the duration of complaints at home and the presence of metastasis at diagnosis during the pre-pandemic and pandemic period in children with cancer. All child...
Saved in:
Published in: | Turkish archives of pediatrics 2023-01, Vol.58 (1), p.75-79 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c493t-690f19a8c2f76445140d3baec28d951e971be0012f815002b1ba1e853e1877a23 |
---|---|
cites | |
container_end_page | 79 |
container_issue | 1 |
container_start_page | 75 |
container_title | Turkish archives of pediatrics |
container_volume | 58 |
creator | Koç, Begüm Şirin Tekkeşin, Funda Haccaloğlu, Elif Ezgi Beyter, Büşra Aydoğdu, Selime Kılıç, Suar Çakı |
description | The lockdown precautions during the COVID-19 pandemic led to concerns about the delayed diagnosis of malignancies. This study aimed to compare the duration of complaints at home and the presence of metastasis at diagnosis during the pre-pandemic and pandemic period in children with cancer.
All children diagnosed with cancer and followed up in our clinic between 2017 and 2022 were included. Patients with a diagnosis of acute/chronic leukemia were excluded. Age, gender, cancer type, duration of complaints, and presence of metastasis at diagnosis of the children were recorded. The duration of complaints and presence of metastasis at diagnosis were compared statistically before and after March 11, 2020, the start point of the COVID-19 pandemic in our country.
A total of 161 patients diagnosed with cancer were analyzed retrospectively; 61% of patients were males and 39% were females. These patients were diagnosed with brain tumors (23.6%), lymphomas (23%), neuroblastoma (13.7%), rhabdomyosarcomas (10.6%), Ewing's sarcoma (4.3%), osteosarcoma (3.7%), Wilm's tumor (3.7%), and germ cell tumors (3.1%). The duration of complaint was longer during the pandemic than before the pandemic (median: 45 days vs. 30 days) (P < .05). The presence of metastases at diagnosis was 45.3% in the prepandemic period, while it was 40% during the pandemic with no statistical difference (P > .5).
We concluded that the duration of complaint before diagnosis was longer during the pandemic, while this delay did not affect the metastasis rate at diagnosis in children with cancer. The high rates of distant metastases in newly diagnosed patients both before and during the pandemic suggest that more studies are needed to diagnose these patients earlier. |
doi_str_mv | 10.5152/TurkArchPediatr.2022.22224 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9885817</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2760820562</sourcerecordid><originalsourceid>FETCH-LOGICAL-c493t-690f19a8c2f76445140d3baec28d951e971be0012f815002b1ba1e853e1877a23</originalsourceid><addsrcrecordid>eNpVkN9LwzAQgIMobsz9CxJ88qUzSZsmeVFG64_BYHuYPgklbdM12iYzaYX99246Zd7LHdzd93EHwBVGE4opuVn17n3qinqpSi07NyGIkAnZRXQChoRRFsSExqdH9QCMvX9DCBEmwihm52AQxlRwgukQvE7NFibWFMoZOM1t38FUNXLroTawqxVMtVwb67WHtoJJrZuytraEidyveJj2Tpv192SyeJmlARZwKU2pWl3cXYCzSjZejQ95BJ4f7lfJUzBfPM6S6TwoIhF2QSxQhYXkBalYHEUUR6gMc6kKwktBsRIM5wohTCqO6e6MHOcSK05DhTljkoQjcPvD3fR5q8pCmc7JJts43Uq3zazU2f-O0XW2tp-Z4JxyzHaA6wPA2Y9e-S5rtS9U00ijbO8zwmLECaLx3nV57PqT_L40_ALw7Hyw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2760820562</pqid></control><display><type>article</type><title>Any Concern About Delays in the Diagnosis of Childhood Cancers During the COVID-19 Pandemic?</title><source>Open Access: PubMed Central</source><source>DOAJ Directory of Open Access Journals</source><creator>Koç, Begüm Şirin ; Tekkeşin, Funda ; Haccaloğlu, Elif Ezgi ; Beyter, Büşra ; Aydoğdu, Selime ; Kılıç, Suar Çakı</creator><creatorcontrib>Koç, Begüm Şirin ; Tekkeşin, Funda ; Haccaloğlu, Elif Ezgi ; Beyter, Büşra ; Aydoğdu, Selime ; Kılıç, Suar Çakı</creatorcontrib><description>The lockdown precautions during the COVID-19 pandemic led to concerns about the delayed diagnosis of malignancies. This study aimed to compare the duration of complaints at home and the presence of metastasis at diagnosis during the pre-pandemic and pandemic period in children with cancer.
All children diagnosed with cancer and followed up in our clinic between 2017 and 2022 were included. Patients with a diagnosis of acute/chronic leukemia were excluded. Age, gender, cancer type, duration of complaints, and presence of metastasis at diagnosis of the children were recorded. The duration of complaints and presence of metastasis at diagnosis were compared statistically before and after March 11, 2020, the start point of the COVID-19 pandemic in our country.
A total of 161 patients diagnosed with cancer were analyzed retrospectively; 61% of patients were males and 39% were females. These patients were diagnosed with brain tumors (23.6%), lymphomas (23%), neuroblastoma (13.7%), rhabdomyosarcomas (10.6%), Ewing's sarcoma (4.3%), osteosarcoma (3.7%), Wilm's tumor (3.7%), and germ cell tumors (3.1%). The duration of complaint was longer during the pandemic than before the pandemic (median: 45 days vs. 30 days) (P < .05). The presence of metastases at diagnosis was 45.3% in the prepandemic period, while it was 40% during the pandemic with no statistical difference (P > .5).
We concluded that the duration of complaint before diagnosis was longer during the pandemic, while this delay did not affect the metastasis rate at diagnosis in children with cancer. The high rates of distant metastases in newly diagnosed patients both before and during the pandemic suggest that more studies are needed to diagnose these patients earlier.</description><identifier>ISSN: 2757-6256</identifier><identifier>EISSN: 2757-6256</identifier><identifier>DOI: 10.5152/TurkArchPediatr.2022.22224</identifier><identifier>PMID: 36598215</identifier><language>eng</language><publisher>Turkey: Turkish Pediatrics Association</publisher><subject>Original</subject><ispartof>Turkish archives of pediatrics, 2023-01, Vol.58 (1), p.75-79</ispartof><rights>2023 authors 2023 authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c493t-690f19a8c2f76445140d3baec28d951e971be0012f815002b1ba1e853e1877a23</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885817/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885817/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36598215$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Koç, Begüm Şirin</creatorcontrib><creatorcontrib>Tekkeşin, Funda</creatorcontrib><creatorcontrib>Haccaloğlu, Elif Ezgi</creatorcontrib><creatorcontrib>Beyter, Büşra</creatorcontrib><creatorcontrib>Aydoğdu, Selime</creatorcontrib><creatorcontrib>Kılıç, Suar Çakı</creatorcontrib><title>Any Concern About Delays in the Diagnosis of Childhood Cancers During the COVID-19 Pandemic?</title><title>Turkish archives of pediatrics</title><addtitle>Turk Arch Pediatr</addtitle><description>The lockdown precautions during the COVID-19 pandemic led to concerns about the delayed diagnosis of malignancies. This study aimed to compare the duration of complaints at home and the presence of metastasis at diagnosis during the pre-pandemic and pandemic period in children with cancer.
All children diagnosed with cancer and followed up in our clinic between 2017 and 2022 were included. Patients with a diagnosis of acute/chronic leukemia were excluded. Age, gender, cancer type, duration of complaints, and presence of metastasis at diagnosis of the children were recorded. The duration of complaints and presence of metastasis at diagnosis were compared statistically before and after March 11, 2020, the start point of the COVID-19 pandemic in our country.
A total of 161 patients diagnosed with cancer were analyzed retrospectively; 61% of patients were males and 39% were females. These patients were diagnosed with brain tumors (23.6%), lymphomas (23%), neuroblastoma (13.7%), rhabdomyosarcomas (10.6%), Ewing's sarcoma (4.3%), osteosarcoma (3.7%), Wilm's tumor (3.7%), and germ cell tumors (3.1%). The duration of complaint was longer during the pandemic than before the pandemic (median: 45 days vs. 30 days) (P < .05). The presence of metastases at diagnosis was 45.3% in the prepandemic period, while it was 40% during the pandemic with no statistical difference (P > .5).
We concluded that the duration of complaint before diagnosis was longer during the pandemic, while this delay did not affect the metastasis rate at diagnosis in children with cancer. The high rates of distant metastases in newly diagnosed patients both before and during the pandemic suggest that more studies are needed to diagnose these patients earlier.</description><subject>Original</subject><issn>2757-6256</issn><issn>2757-6256</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpVkN9LwzAQgIMobsz9CxJ88qUzSZsmeVFG64_BYHuYPgklbdM12iYzaYX99246Zd7LHdzd93EHwBVGE4opuVn17n3qinqpSi07NyGIkAnZRXQChoRRFsSExqdH9QCMvX9DCBEmwihm52AQxlRwgukQvE7NFibWFMoZOM1t38FUNXLroTawqxVMtVwb67WHtoJJrZuytraEidyveJj2Tpv192SyeJmlARZwKU2pWl3cXYCzSjZejQ95BJ4f7lfJUzBfPM6S6TwoIhF2QSxQhYXkBalYHEUUR6gMc6kKwktBsRIM5wohTCqO6e6MHOcSK05DhTljkoQjcPvD3fR5q8pCmc7JJts43Uq3zazU2f-O0XW2tp-Z4JxyzHaA6wPA2Y9e-S5rtS9U00ijbO8zwmLECaLx3nV57PqT_L40_ALw7Hyw</recordid><startdate>20230101</startdate><enddate>20230101</enddate><creator>Koç, Begüm Şirin</creator><creator>Tekkeşin, Funda</creator><creator>Haccaloğlu, Elif Ezgi</creator><creator>Beyter, Büşra</creator><creator>Aydoğdu, Selime</creator><creator>Kılıç, Suar Çakı</creator><general>Turkish Pediatrics Association</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230101</creationdate><title>Any Concern About Delays in the Diagnosis of Childhood Cancers During the COVID-19 Pandemic?</title><author>Koç, Begüm Şirin ; Tekkeşin, Funda ; Haccaloğlu, Elif Ezgi ; Beyter, Büşra ; Aydoğdu, Selime ; Kılıç, Suar Çakı</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c493t-690f19a8c2f76445140d3baec28d951e971be0012f815002b1ba1e853e1877a23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koç, Begüm Şirin</creatorcontrib><creatorcontrib>Tekkeşin, Funda</creatorcontrib><creatorcontrib>Haccaloğlu, Elif Ezgi</creatorcontrib><creatorcontrib>Beyter, Büşra</creatorcontrib><creatorcontrib>Aydoğdu, Selime</creatorcontrib><creatorcontrib>Kılıç, Suar Çakı</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Turkish archives of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koç, Begüm Şirin</au><au>Tekkeşin, Funda</au><au>Haccaloğlu, Elif Ezgi</au><au>Beyter, Büşra</au><au>Aydoğdu, Selime</au><au>Kılıç, Suar Çakı</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Any Concern About Delays in the Diagnosis of Childhood Cancers During the COVID-19 Pandemic?</atitle><jtitle>Turkish archives of pediatrics</jtitle><addtitle>Turk Arch Pediatr</addtitle><date>2023-01-01</date><risdate>2023</risdate><volume>58</volume><issue>1</issue><spage>75</spage><epage>79</epage><pages>75-79</pages><issn>2757-6256</issn><eissn>2757-6256</eissn><abstract>The lockdown precautions during the COVID-19 pandemic led to concerns about the delayed diagnosis of malignancies. This study aimed to compare the duration of complaints at home and the presence of metastasis at diagnosis during the pre-pandemic and pandemic period in children with cancer.
All children diagnosed with cancer and followed up in our clinic between 2017 and 2022 were included. Patients with a diagnosis of acute/chronic leukemia were excluded. Age, gender, cancer type, duration of complaints, and presence of metastasis at diagnosis of the children were recorded. The duration of complaints and presence of metastasis at diagnosis were compared statistically before and after March 11, 2020, the start point of the COVID-19 pandemic in our country.
A total of 161 patients diagnosed with cancer were analyzed retrospectively; 61% of patients were males and 39% were females. These patients were diagnosed with brain tumors (23.6%), lymphomas (23%), neuroblastoma (13.7%), rhabdomyosarcomas (10.6%), Ewing's sarcoma (4.3%), osteosarcoma (3.7%), Wilm's tumor (3.7%), and germ cell tumors (3.1%). The duration of complaint was longer during the pandemic than before the pandemic (median: 45 days vs. 30 days) (P < .05). The presence of metastases at diagnosis was 45.3% in the prepandemic period, while it was 40% during the pandemic with no statistical difference (P > .5).
We concluded that the duration of complaint before diagnosis was longer during the pandemic, while this delay did not affect the metastasis rate at diagnosis in children with cancer. The high rates of distant metastases in newly diagnosed patients both before and during the pandemic suggest that more studies are needed to diagnose these patients earlier.</abstract><cop>Turkey</cop><pub>Turkish Pediatrics Association</pub><pmid>36598215</pmid><doi>10.5152/TurkArchPediatr.2022.22224</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2757-6256 |
ispartof | Turkish archives of pediatrics, 2023-01, Vol.58 (1), p.75-79 |
issn | 2757-6256 2757-6256 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9885817 |
source | Open Access: PubMed Central; DOAJ Directory of Open Access Journals |
subjects | Original |
title | Any Concern About Delays in the Diagnosis of Childhood Cancers During the COVID-19 Pandemic? |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T19%3A20%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Any%20Concern%20About%20Delays%20in%20the%20Diagnosis%20of%20Childhood%20Cancers%20During%20the%20COVID-19%20Pandemic?&rft.jtitle=Turkish%20archives%20of%20pediatrics&rft.au=Ko%C3%A7,%20Beg%C3%BCm%20%C5%9Eirin&rft.date=2023-01-01&rft.volume=58&rft.issue=1&rft.spage=75&rft.epage=79&rft.pages=75-79&rft.issn=2757-6256&rft.eissn=2757-6256&rft_id=info:doi/10.5152/TurkArchPediatr.2022.22224&rft_dat=%3Cproquest_pubme%3E2760820562%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c493t-690f19a8c2f76445140d3baec28d951e971be0012f815002b1ba1e853e1877a23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2760820562&rft_id=info:pmid/36598215&rfr_iscdi=true |